News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

T2 Biosystems Presents New Data At The Thrombosis And Hemostasis Summit Of North America Demonstrating Ability Of T2MR Platform Technology To Measure Platelet Activity And Additional Hemostasis Parameters


4/10/2014 7:31:28 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

T2 Biosystems, a company developing direct detection products designed to enable superior diagnostics, today announced the presentation of data highlighting the role of its T2MR platform technology in measuring platelet function, an important parameter in assessing hemostasis and thrombosis. The company will also present data on the use of T2MR to deliver multiplex hemostasis results that include clotting time and fibrinogen generated by the company’s investigational T2Stat instrument and T2HemoStat panel, which run on the T2MR platform.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES